Deutsche Bank AG acquired a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 190,914 shares of the company's stock, valued at approximately $1,890,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC raised its holdings in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock valued at $29,000 after buying an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new stake in shares of Avantor during the 2nd quarter worth about $32,000. Los Angeles Capital Management LLC acquired a new position in shares of Avantor during the 4th quarter valued at about $32,000. Osaic Holdings Inc. raised its stake in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after acquiring an additional 1,064 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its stake in shares of Avantor by 1,599.7% in the 1st quarter. SJS Investment Consulting Inc. now owns 5,235 shares of the company's stock valued at $41,000 after acquiring an additional 4,927 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on AVTR. Citigroup upped their price objective on shares of Avantor from $9.00 to $11.00 and gave the stock a "neutral" rating in a report on Wednesday, July 8th. Sanford C. Bernstein began coverage on shares of Avantor in a report on Friday, June 26th. They set a "market perform" rating and a $10.50 price target for the company. Barclays raised their price target on Avantor from $7.00 to $8.00 and gave the company an "underweight" rating in a research report on Wednesday, June 24th. TD Cowen reissued a "hold" rating on shares of Avantor in a research report on Wednesday, July 15th. Finally, Wall Street Zen raised Avantor from a "hold" rating to a "buy" rating in a report on Saturday, June 27th. Two equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $12.00.
Get Our Latest Report on Avantor
Avantor Stock Down 0.1%
Shares of NYSE AVTR opened at $14.60 on Friday. The firm's 50-day simple moving average is $12.12 and its 200 day simple moving average is $9.77. The company has a market cap of $9.87 billion, a price-to-earnings ratio of -17.38, a price-to-earnings-growth ratio of 11.03 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93.
Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same period last year, the company earned $0.24 EPS. The business's quarterly revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, research analysts expect that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.
Avantor Company Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.